• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检查的淋巴结数量对接受肺叶下切除的IA期非小细胞肺癌患者生存率的影响。

Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection.

作者信息

Liu Yang, Shen Jianfei, Liu Liping, Shan Lanlan, He Jiaxi, He Qihua, Jiang Long, Guo Minzhang, Chen Xuewei, Pan Hui, Peng Guilin, Shi Honghui, Ou Limin, Liang Wenhua, He Jianxing

机构信息

Department of Thoracic Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.

Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou 317000, China.

出版信息

J Thorac Dis. 2018 Dec;10(12):6569-6577. doi: 10.21037/jtd.2018.11.49.

DOI:10.21037/jtd.2018.11.49
PMID:30746202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6344684/
Abstract

BACKGROUND

The correlation between the number of examined lymph nodes (ELNs) and lung cancer-specific survival (LCSS) of stage IA non-small cell lung cancer (NSCLC) patients, who underwent sublobar resection in which lymph node (LN) sampling was relatively restricted as compared with standard lobectomy remains unclear.

METHODS

Patients from the Surveillance, Epidemiology, and End Results database with stage IA NSCLC who underwent sublobar resection were categorized based on ELN count (1-6 ≥7; the cut point 7 was identified by Cox model).

RESULTS

Collectively, 3,219 patients with a median follow-up time of 37 months were included in this study (G1: 1-6 ELN, n=2,410; G2: ≥7 ELN, n=809). The 5-year LCSS rate of the G1 and G2 cohorts were 75% and 83%, respectively. Cox analysis suggested that the LCSS of G1 cohort patients was lower as compared with the G2 cohort [hazard ratio (HR) =1.530; 95% confidence interval (CI): 1.240-1.988, P<0.001). Propensity score analysis also showed decreased survival of the matched G1 cohort (HR =1.499; 95% CI: 1.176-1.911; P=0.001).

CONCLUSIONS

The data suggested the ELNs ≤6 were associated with poor prognoses. Adequate LN sampling is essential even for stage IA NSCLC patients undergoing sublobar resection.

摘要

背景

对于接受亚肺叶切除的IA期非小细胞肺癌(NSCLC)患者,其检查的淋巴结数量(ELN)与肺癌特异性生存率(LCSS)之间的相关性尚不清楚,与标准肺叶切除术相比,亚肺叶切除术中淋巴结(LN)采样相对受限。

方法

将监测、流行病学和最终结果数据库中接受亚肺叶切除的IA期NSCLC患者根据ELN计数进行分类(1 - 6个≥7个;切点7由Cox模型确定)。

结果

本研究共纳入3219例患者,中位随访时间为37个月(G1组:1 - 6个ELN,n = 2410;G2组:≥7个ELN,n = 809)。G1组和G2组的5年LCSS率分别为75%和83%。Cox分析表明,与G2组相比,G1组患者的LCSS较低[风险比(HR)= 1.530;95%置信区间(CI):1.240 - 1.988,P < 0.001]。倾向评分分析也显示匹配的G1组生存率降低(HR = 1.499;95% CI:1.176 - 1.911;P = 0.001)。

结论

数据表明ELN≤6与预后不良相关。即使对于接受亚肺叶切除的IA期NSCLC患者,充分的LN采样也至关重要。

相似文献

1
Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection.检查的淋巴结数量对接受肺叶下切除的IA期非小细胞肺癌患者生存率的影响。
J Thorac Dis. 2018 Dec;10(12):6569-6577. doi: 10.21037/jtd.2018.11.49.
2
Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.亚肺叶切除治疗ⅠA 期非小细胞肺癌时淋巴结清扫数目对预后的影响:基于人群的分析。
Clin Lung Cancer. 2021 Jul;22(4):e563-e573. doi: 10.1016/j.cllc.2020.09.015. Epub 2020 Oct 14.
3
Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.≤35岁的IA期非小细胞肺癌患者行肺叶下切除与肺叶切除的比较:一项监测、流行病学和最终结果(SEER)数据库分析
J Cancer Res Clin Oncol. 2017 Nov;143(11):2375-2382. doi: 10.1007/s00432-017-2499-y. Epub 2017 Aug 17.
4
Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer ≤2 cm.亚肺叶切除术治疗≤2cmⅠA 期非小细胞肺癌的淋巴结清扫术对结局的预后影响。
J Thorac Cardiovasc Surg. 2018 Aug;156(2):796-805.e4. doi: 10.1016/j.jtcvs.2018.03.122. Epub 2018 Apr 6.
5
Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.临床ⅠA 期肺癌的长期结果:肺叶切除术与亚肺叶切除术比较。
Ann Thorac Surg. 2018 Aug;106(2):375-381. doi: 10.1016/j.athoracsur.2018.02.049. Epub 2018 Mar 23.
6
Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.肺叶切除与肺段切除术后IA期非小细胞肺癌中淋巴管侵犯的预后影响比较:一项倾向评分匹配分析。
Lung Cancer. 2020 Aug;146:105-111. doi: 10.1016/j.lungcan.2020.04.033. Epub 2020 May 16.
7
Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.IA期老年非小细胞肺癌患者(≥70岁)肺叶切除术与肺段切除术的比较:一项基于人群的倾向评分匹配研究。
Front Oncol. 2021 May 7;11:610638. doi: 10.3389/fonc.2021.610638. eCollection 2021.
8
Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.右中叶早期非小细胞肺癌行肺叶切除术与亚肺叶切除术的生存率。
Thorac Cancer. 2018 Aug;9(8):1026-1031. doi: 10.1111/1759-7714.12782. Epub 2018 Jun 21.
9
Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.淋巴结清扫数目对接受亚肺叶切除术的Ⅰ期非小细胞肺癌患者生存的影响。
J Thorac Cardiovasc Surg. 2018 Jul;156(1):394-402. doi: 10.1016/j.jtcvs.2018.03.113. Epub 2018 Apr 4.
10
Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.美国临床IA期非小细胞肺癌的肺叶下切除术
Clin Lung Cancer. 2016 Jan;17(1):47-55. doi: 10.1016/j.cllc.2015.07.005. Epub 2015 Aug 3.

引用本文的文献

1
Impact of examined lymph node count on survival outcomes in patients with stage T1-2N0M0 small cell lung cancer undergoing surgery: A retrospective cohort study.探讨接受手术治疗的 T1-2N0M0 期小细胞肺癌患者的检查淋巴结数量对生存结局的影响:一项回顾性队列研究。
Medicine (Baltimore). 2024 May 31;103(22):e38381. doi: 10.1097/MD.0000000000038381.
2
Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.有淋巴结转移的患者比例对可切除非小细胞肺癌患者总生存期的意义:一项回顾性队列研究。
Eur J Cancer Prev. 2024 Jul 1;33(4):376-385. doi: 10.1097/CEJ.0000000000000868. Epub 2024 May 16.
3
The Role of Sublobar Resection for the Surgical Treatment of Non-Small Cell Lung Cancer.亚肺叶切除术在非小细胞肺癌外科治疗中的作用。
Curr Oncol. 2023 Jul 22;30(7):7019-7030. doi: 10.3390/curroncol30070509.
4
Editorial: Surgical Selection of Sublobar Resection and Scope of Lymph Node Dissection for Early-Stage Lung Cancer.社论:早期肺癌肺叶下切除的手术选择及淋巴结清扫范围
Front Surg. 2022 May 11;9:915220. doi: 10.3389/fsurg.2022.915220. eCollection 2022.
5
Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study.亚肺叶切除术与肺叶切除术治疗老年早期肺类癌肿瘤患者的长期生存分析:基于数据库的倾向评分匹配研究。
Aging Clin Exp Res. 2022 Aug;34(8):1925-1934. doi: 10.1007/s40520-022-02112-0. Epub 2022 Mar 28.
6
Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.辅助治疗可改善肺叶切除术后≤3 cm非小细胞肺癌患者的预后:一项倾向评分分析
J Thorac Dis. 2021 Jan;13(1):312-321. doi: 10.21037/jtd-20-3448.
7
A Machine Learning-Based Investigation of Gender-Specific Prognosis of Lung Cancers.基于机器学习的肺癌性别特异性预后研究。
Medicina (Kaunas). 2021 Jan 22;57(2):99. doi: 10.3390/medicina57020099.
8
Prognostic impact of lymphadenectomy on outcomes of sublobar resection for non-small cell lung cancer ≤1 or >1 to 2 cm.淋巴结清扫术对直径≤1cm或>1至2cm的非小细胞肺癌亚肺叶切除术后结局的预后影响
J Thorac Dis. 2020 May;12(5):2049-2060. doi: 10.21037/jtd-19-3773.

本文引用的文献

1
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.检查的淋巴结数量对切除的非小细胞肺癌精确分期及长期生存的影响:一项基于美国监测、流行病学和最终结果(SEER)数据库及中国多机构登记处的人群研究
J Clin Oncol. 2017 Apr 10;35(11):1162-1170. doi: 10.1200/JCO.2016.67.5140. Epub 2016 Dec 28.
2
The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.对于临床IA期肺癌,楔形切除术中进行淋巴结清扫的重要性。
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):511-517. doi: 10.1093/ejcts/ezw343.
3
Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.非小细胞肺癌切除术中清扫淋巴结最少数量的理论依据:98970例患者清扫淋巴结数量与生存情况的相关性
Ann Surg Oncol. 2016 Dec;23(Suppl 5):1005-1011. doi: 10.1245/s10434-016-5509-4. Epub 2016 Aug 16.
4
Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non-Small Cell Lung Cancer.解剖性肺段切除术和楔形切除术治疗 cT1N0 期非小细胞肺癌患者的疗效相当。
J Thorac Oncol. 2016 Nov;11(11):1984-1992. doi: 10.1016/j.jtho.2016.06.031. Epub 2016 Aug 3.
5
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.非小细胞肺癌切除术后肺内淋巴结转移漏诊与生存情况
Ann Thorac Surg. 2016 Aug;102(2):448-53. doi: 10.1016/j.athoracsur.2016.03.096. Epub 2016 Jun 3.
6
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
7
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
8
Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.美国临床IA期非小细胞肺癌的肺叶下切除术
Clin Lung Cancer. 2016 Jan;17(1):47-55. doi: 10.1016/j.cllc.2015.07.005. Epub 2015 Aug 3.
9
The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer.肿瘤大小对临床I期非小细胞肺癌淋巴结切除范围与生存关联的影响。
Lung Cancer. 2015 Dec;90(3):554-60. doi: 10.1016/j.lungcan.2015.10.011. Epub 2015 Oct 14.
10
Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy.淋巴结评估及其对电视辅助胸腔镜肺叶切除术或肺段切除术患者生存的影响
Ann Thorac Surg. 2015 Sep;100(3):910-6. doi: 10.1016/j.athoracsur.2015.04.034. Epub 2015 Jul 10.